Person
| Role | Organisation | Sources |
|---|---|---|
| No role recorded yet. Adel Nada has been mentioned, but not yet attached to an organisation. Know their role? | ||
Stories naming Adel Nada. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
FytonBio secured one million dollars in pre-seed funding from Breakthrough Victoria and Monash University to develop antibody therapies for autoimmune diseases using Monash's GREAT platform.
Weekly roundup: Breakthrough Victoria and Monash University co-invest $2.25 million across three university healthtech spinouts, while Blackbird backs Hall, which helps businesses win visibility on AI platforms, with $2 million pre-seed.
Also Startup Daily